Ngā hua rapu - Danilo Fliser

Whakamahine hua
  1. 1
    Clinical relevance of FGF-23 in chronic kidney disease

    Clinical relevance of FGF-23 in chronic kidney disease mā Sarah Seiler, Gunnar H. Heine, Danilo Fliser

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Calcium and phosphate impact cardiovascular risk

    Calcium and phosphate impact cardiovascular risk mā Gunnar H. Heine, Masaomi Nangaku, Danilo Fliser

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    FGF-23: the rise of a novel cardiovascular risk marker in CKD

    FGF-23: the rise of a novel cardiovascular risk marker in CKD mā Gunnar H. Heine, Sarah Seiler, Danilo Fliser

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure

    Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure mā Danilo Fliser, M. Schröter, Monika Neubeck, Eberhard Ritz

    I whakaputaina 1994
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Innate immunity in CKD-associated vascular diseases

    Innate immunity in CKD-associated vascular diseases mā Stephen Zewinger, Timo Schumann, Danilo Fliser, Thimoteus Speer

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Renal functional reserve in healthy elderly subjects.

    Renal functional reserve in healthy elderly subjects. mā Danilo Fliser, M. Zeier, Rainer Nowack, Eberhard Ritz

    I whakaputaina 1993
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Renal findings in patients with short-term type 2 diabetes.

    Renal findings in patients with short-term type 2 diabetes. mā Christine K. Keller, K. Bergis, Danilo Fliser, Eberhard Ritz

    I whakaputaina 1996
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Cardiovascular Disease in Chronic Kidney Disease

    Cardiovascular Disease in Chronic Kidney Disease mā Joachim Jankowski, Jürgen Floege, Danilo Fliser, Michael Böhm, Nikolaus Marx

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease

    Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease mā Christof Ulrich, Gunnar H. Heine, Eric Seibert, Danilo Fliser, Matthias Girndt

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Chronic Angiotensin II Receptor Blockade Reduces (Intra)Renal Vascular Resistance in Patients with Type 2 Diabetes

    Chronic Angiotensin II Receptor Blockade Reduces (Intra)Renal Vascular Resistance in Patients with Type 2 Diabetes mā Danilo Fliser, Kathrin-Kristin Wagner, Astrid Loos, Dimitrios Tsikas, Hermann Haller

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Renal function in the elderly: Impact of hypertension and cardiac function

    Renal function in the elderly: Impact of hypertension and cardiac function mā Danilo Fliser, Edward Franek, Markus Joest, Stefan Block, Ernst Mutschler, Eberhard Ritz

    I whakaputaina 1997
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis

    Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis mā Sascha David, P. Kumpers, V. Seidler, Frank Biertz, Hermann Haller, Danilo Fliser

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Lipoproteins in chronic kidney disease: from bench to bedside

    Lipoproteins in chronic kidney disease: from bench to bedside mā Thimoteus Speer, Paul M. Ridker, Arnold von Eckardstein, Stefan Schunk, Danilo Fliser

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

    FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment mā Sarah Seiler, B Reichart, Daniel Röth, Eric Seibert, Danilo Fliser, Gunnar H. Heine

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction

    Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction mā Matthias Klingele, Theresa Stadler, Danilo Fliser, Thimoteus Speer, Heinrich V. Groesdonk, Alexander Raddatz

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study

    Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study mā Barbara Kollerits, Danilo Fliser, Iris M. Heid, Eberhard Ritz, Florian Kronenberg, for the MMKD Study Group

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Stimulation of Endothelial Progenitor Cells

    Stimulation of Endothelial Progenitor Cells mā Ferdinand H. Bahlmann, Kirsten de Groot, Ottfried Mueller, Barbara Hertel, Hermann Haller, Danilo Fliser

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Coadministration of albumin and furosemide in patients with the nephrotic syndrome

    Coadministration of albumin and furosemide in patients with the nephrotic syndrome mā Danilo Fliser, Ines Zurbrüggen, E. Mutschler, Irene Bischoff, Jürg Nussberger, Edward Franek, Eberhard Ritz

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis

    Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis mā Jan T. Kielstein, Shelley R. Salpeter, Stefanie M. Bode-Boeger, John P. Cooke, Danilo Fliser

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease

    Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease mā Bjoern Becker, Florian Kronenberg, Jan T. Kielstein, Hermann Haller, Christian Morath, Eberhard Ritz, Danilo Fliser

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: